{"id":"W4413787387","doi":"10.1158/1078-0432.ccr-25-1648","title":"A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"BeiGene; Merck KGaA; American Association for Cancer Research; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Medicine; Adverse effect; Pharmacokinetics; Rash; Tolerability; Maculopapular rash; Toxicity; Pharmacodynamics; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacology; Anemia; Mucositis; Gastroenterology; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00194341,0.001440297,0.001946524,0.0003599809,0.0004081304,0.001029268,0.0006861541,0.0009097088,0.003636697],"category_scores_gemma":[0.001009061,0.0006392261,0.001274653,0.0003779565,0.0009268435,0.001102769,0.000277784,0.003122198,0.000966606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001086232,"about_ca_system_score_gemma":0.001582036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006220636,"about_ca_topic_score_gemma":0.001908915,"domain_scores_codex":[0.9993201,0.0003561113,0.0000349599,0.0001124001,0.00007986595,0.00009667874],"domain_scores_gemma":[0.9993042,0.0001302415,0.0001690066,0.00008299799,0.00006156803,0.0002519813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4639143,0.1841735,0.01541998,0.00184325,0.002503238,0.0007392794,0.0004877018,0.004660879,0.1562562,0.0003726081,0.006123542,0.1635055],"study_design_scores_gemma":[0.1763112,0.795339,0.01135883,0.00003351867,0.0005215243,0.0005443358,0.0000716435,0.001572559,0.01037348,0.0001336952,0.003700668,0.00003958949],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936871,0.001894444,0.0007108275,0.0002926134,0.0001066309,0.001218002,0.0008334699,0.0001002255,0.001156759],"genre_scores_gemma":[0.9913078,0.001474146,0.001373048,0.0005765351,0.0001891613,0.0009509313,0.00168623,0.00004025871,0.00240188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003636697,"threshold_uncertainty_score":0.0121659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03361998146685217,"score_gpt":0.4489923089937287,"score_spread":0.4153723275268765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}